Clinical Trial Update: Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial of valomaciclovir for infectious mononucleosis due to primary Epstein-Barr virus infection; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Mononucleosis

Drugs mentioned

• Valomaciclovir (valomaciclovir)

Snippet

Sponsor: University of Minnesota | Conditions: Infectious Mononucleosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-17